source
- Kailera says obesity pill succeeds in late-stage trial in ChinaThe drug spurred about 10% weight loss over 10 months, though that finding came alongside high rates of gastrointestinal side effects that “alarmed” one analyst.BioPharma Dive · 1mo ago↗ source
- STAT+: Compass says depression drug has long-lasting benefitsVertex makes its largest-ever deal, skyrocketing health insurance costs, and more biotech news from The ReadoutSTAT · 1mo ago↗ source
- Vertex to acquire Crinetics in $10B foray into endocrine disease drugsVertex claimed the two drugs in the deal could eventually bring in more than $5 billion annually. Still, the high price it paid stirred debate among analysts and investors.BioPharma Dive · 1mo ago